RICHMOND, BRITISH COLUMBIA--(Marketwire - Sept. 10, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV) announces that its Metricath Libra® arterial and in-stent measurement system was shown in a pilot study to be effective for use in renal arteries, according to results shared at the New Cardiovascular Horizons (NCVH) conference in New Orleans.
